Fatih Teker

Education:

• 19 Mayıs University Faculty of Medicine, Medical Oncology Specialization Training (2011-2014)
• Istanbul Taksim Training and Research Hospital Internal Medicine Specialization Training (2005-2010)
• 19 Mayıs University Faculty of Medicine Medical Doctorate Education (1996-2002)

Experience:

• Liv Hospital Gaziantep (2024-)
• Gaziantep University Faculty of Medicine, Head of Medical Oncology Department - Professor (2018-2024)
• Kocaeli State Hospital, Medical Oncology Responsible Physician-Associate Professor (2017-2018)
• Diyarbakır Gazi Yaşargil Training and Research Hospital, Internal Medicine Clinic, Associate Professor (Civil Service Obligation 2015-2017)
• University of Rotterdam Netherlands, Research Fellow (2011)
• Turkish Armed Forces, Medical Lieutenant, Sarıkamış-Kars (2003-2004)
• General Practitioner (2002-2003)

Research:

1 Real World Effectiveness Data and Safety in Patients Receiving Pazopanib with Advanced or Metastatic Renal Cell Carcinoma (PRINCIPAL) 2015
2 Regorafenib in Subjects with Metastatic Colorectal Cancer (mCRC) Who Have Progressed After Standard Therapy (REGARD) 2019
3 A Multicenter, Randomized, Double-blind, Phase III Study of BAT1706 versus EU-Avastin® plus Chemotherapy in Patients with Advanced Non - squamous Non-Small Cell Lung Cancer. 2019
4 FIGHT: A Phase 3 Randomized, Double-Blind, Controlled Study Evaluating FPA144 and Modified FOLFOX6 in Patients with Previously Untreated Advanced Gastric and Gastroesophageal Cancer: Phase 3 Preceded by Dose Finding in Phase 1A 2019.
5 A Randomized, Open-Label, International, Multi- Center, Phase 3 Clinical Study of PD-1 Antibody SHR-1210 Plus Apatinib (Rivoceranib) Mesylate Versus Sorafenib as First-Line Therapy in Subjects with Advanced Hepatocellular Carcinoma (HCC) Who Have Not Previously Received Systemic Therapy.
6 Platinum-Based Chemotherapy with/without INCMGA00012, an Anti-PD-1 Antibody, in Non-Small Cell Lung Cancer (POD1UM-304)

Publications:

1 Karacin C, Oksuzoglu B, Demirci A, Keskinkılıç M, Baytemür NK, Yılmaz F, Selvi O, Erdem D, Avşar E, Paksoy N, Demir N, Göksu SS, Türker S, Bayram E, Çelebi A, Yılmaz H, Kuzu ÖF, Kahraman S, Gökmen İ, Sakin A, Alkan A, Nayır E, Uğraklı M, Acar Ö, Ertürk İ, Demir H, Aslan F, Sönmez Ö, Korkmaz T, Celayir ÖM, Karadağ İ, Kayıkçıoğlu E, Şakalar T, Öktem İN, Eren T, Erul E, Mocan EE, Kalkan Z, Yıldırım N, Ergün Y, Akagündüz B, Karakaya S, Kut E, Teker F, Demirel BÇ, Karaboyun K, Almuradova E, Ünal OÜ, Oyman A, Işık D, Okutur K, Öztosun B, Gülbağcı BB, Kalender ME, Şahin E, Seyyar M, Özdemir Ö, Selçukbiricik F, Kanıtez M, Dede İ, Gümüş M, Gökmen E, Yaren A, Menekşe S, Ebinç S, Aksoy S, İmamoğlu Gİ, Altınbaş M, Çetin B, Uluç BO, Er Ö, Karadurmuş N, Erdoğan AP, Artaç M, Tanrıverdi Ö, Çiçin İ, Şendur MAN, Oktay E, Bayoğlu İV, Paydaş S, Aydıner A, Salim DK, Geredeli Ç, Yavuzşen T, Doğan M, Hacıbekiroğlu İ. Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy. BMC Cancer. 2023 Feb 27;23(1):192. BMC Cancer. 2023 Feb 10;23(1):136.
2 Kahraman S, Erul E, Seyyar M, Gumusay O, Bayram E, Demirel BC, Acar O, Aksoy S, Baytemur NK, Sahin E, Cabuk D, Basaran G, Paydas S, Yaren A, Guven DC, Erdogan AP, Demirci U, Yasar A, Bayoglu İV, Hizal M, Gulbagci B, Paksoy N, Davarci SE, Yilmaz F, Dogan O, Orhan SO, Kayikcioglu E, Aytac A, Keskinkilic M, Mocan EE, Unal OU, Aydin E, Yucel H, Isik D, Eren O, Uluc BO, Ozcelik M, Hacibekiroglu I, Aydiner A, Demir H, Oksuzoglu B, Cilbir E, Cubukcu E, Cetin B, Oktay E, Erol C, Okutur SK, Yildirim N, Alkan A, Selcukbiricik F, Aksoy A, Karakas Y, Ozkanli G, Duman BB, Aydin D, Dulgar O, Er MM, Teker F, Yavuzsen T, Aykan MB, Inal A, Iriagac Y, Kalkan NO, Keser M, Sakalar T, Menekse S, Kut E, Bilgin B, Karaoglanoglu M, Sunar V, Ozdemir O, Turhal NS, Karadurmus N, Yalcin B, Nahit Sendur MA. Treatment efficacy of ribociclib or palbociclib plus letrozole in hormone receptor-positive/HER2-negative metastatic breast cancer. Future Oncol. 2023 Mar;19(10):727-736.
3 Aktürk Esen S, Ergun Y, Erol C, Arikan R, Er MM, Atci MM, Topçu A, Uçar G, Akagündüz B, Aykan MB, Özen M, Baytemur NK, Özçelik M, Şahin E, Güven D, Menekşe S, Ak N, Teker F, Kut E, Şakalar T, Alan Ö, Kaçan T, Turhal NS, Kiliçkap S, Türker S, Şendur MAN, Köstek O, Karaağaç M, Sakin A, Türk HM, Çağlayan D, Cihan Ş, Açikgöz Y, Uncu D. First-line treatment of patients with HER2-positive metastatic gastric and gastroesophageal junction cancer. Bosn J Basic Med Sci. 2022 Sep 16;22(5):818-825. First-line treatment of patients with HER2-positive metastatic gastric and gastroesophageal carcinoma
4 Elboga U, Sahin E, Kus T, Cayirli YB, Aktas G, Okuyan M, Cinkir HY, Teker F, Sever ON, Aytekin A, Yılmaz L, Aytekin A, Cimen U, Mumcu V, Kilbas B, Eryilmaz K, Cakici D, Celen YZ. Comparison of 68Ga-FAPI PET/CT and 18FDG PET/CT Modalities in Gastrointestinal System Malignancies with Peritoneal Involvement. Mol Imaging Biol. 2022 Oct;24(5):789-797. 
5 Ilhan Y, Tatli AM, Teker F, Onder AH, Kose F, Geredeli C, Karaagac M, Kaplan MA, Inanc M, Goktas Aydin S, Kargi A, Arak H, Ozturk B, Besen AA, Selvi O, Korkmaz M, Oruc Z, Bozkurt O, Bilici A, Bayram S, Dae SA, Ozdogan M, Coskun HS, Sezgin Goksu S. Cisplatin plus paclitaxel and bevacizumab versus carboplatin plus paclitaxel and bevacizumab for the first-line treatment of metastatic or recurrent cervical cancer. Int J Gynecol Cancer. 2022 Apr 4;32(4):502-507.
6 Teker F, Elboga U. ‘’Is SUVmax a useful marker for progression-free survival in patients with metastatic GEP-NET receiving 177Lu- DOTATATE therapy’’. Hell J Nucl Med. 2021; 24(2): 173-179.
7 Elboga U, Sahin E, Kus T, Cayirli YB, Aktas G, Uzun E, Cinkir HY, Teker F, Sever ON, Aytekin A, Yilmaz L, Aytekin A, Cimen U, Mumcu V, Kilbas B, Çelen YZ. Superiority of 68Ga-FAPI PET/CT scan in detecting additional lesions compared to 18FDG PET/CT scan in breast cancer. Ann Nucl Med. 2021 Dec;35(12):1321-1331. 
8 Havva YEŞİL ÇINKIR, Özlem Nuray SEVER, Fatih TEKER. Vismodegib for Patients with Advanced Basal Cell Carcinoma One Center’s Experience. Journal of Oncological Sciences 2020; 6(1): 5-9.
9 Aslan Çelebi, Fatih Teker, Mujgan Gurler, Deniz Ogutmen Koc, Ali Abbas Ozdemir, Ismail Ekizoglu and Murat Altay. '' Characteristics of the Patients Undergoing Colonoscopy in a Single Center within an 8-year Period ''. J Gastrointest Dig Syst. 2017 7; 3.
10 Yilmaz B, Erdem D, Teker F, Goren I, Yildirim B, Kut E, Sarikaya D, Atay MH, Yucel I. '' The effect of anticancer therapy on anti-hepatitis B antibody titres in patients with haematological malignancies and solid tumours ''. J Int Med Res. 2016 Jun;44(3):627-38.
11 Tanriverdi O, Menekse S, Teker F, Oktay E, Nur Pilanc K, Gunaldi M, Kocar M, Kacan T, Bahceci A, Avci N, Akman T, Cokmert S, Yesil-Cinkir H, Teoman Yanmaz M. '' The mean platelet volume may predict the development of isolated bone metastases in patients with breast cancer: a retrospective study of the Young Researchers Committee of the Turkish Oncology Group (TOG) '' . J BUON. 2016 Jul-Aug;21(4):840-850.
12 Teker F, Demirag G, Erdem D, Kemal Y, Yucel I. '' Quality of life in colorectal cancer patients during chemotherapy in the era of monoclonal antibody therapies ''. J BUON. 2015 Mar-Apr;20(2):443-51.
13 Teker F, Canbaz F, Kemal Y, Yucel I. A case of gastric cancer with liver metastases had a complete response with cisplatin and capecitabine as third-line chemotherapy. J Cancer Res Ther. 2015 Oct-Dec;11(4):1026.
14 Kemal Y, Demirag G, Teker F, Kut E, Kefeli M, Ekiz K, Yucel I. '' High body-mass index is not associated with worse clinicopathological characteristics in predominantly obese breast cancer patients '' Exp Oncol. 2015 Dec;37(4):281-4.
15 Kemal Y, Teker F, Demirag G, Yucel I. '' Primary testicular lymphoma: a single centre experience ''. Exp Oncol. 2015 Sep;37(3):223-6.
16 Teker F, Kemal Y, Yilmaz B, Ekinci AS, Güney Y, Bek Y, Turgut M, Yücel I. '' RDW is a novel prognostic parameter in diffuse large B cell lymphoma in the Rituximab era ''. JJ Biomark. 2015, 1(2):009.
17 Kemal Y, Demirag G, Baş B, Önem S, Teker F, Yücel İ. '' The value of red blood cell distribution width in endometrial cancer ''. Clin Chem Lab Med. 2015 Apr;53(5):823-7
18 Teker F, Yilmaz B, Kemal Y, Kut E, Yucel I. '' Efficacy and safety of docetaxel or epirubicin, combined with cisplatin and fluorouracil (DCF and ECF), regimens as first line chemotherapy for advanced gastric cancer: a retrospective analysis from Turkey ''. Asian Pac J Cancer Prev. 2014;15(16):6727-32.
19 Yilmaz B, Kemal Y, Teker F, Kut E, Demirag G, Yucel I. '' Single dose regorafenib-induced hypertensive crisis ''. Exp Oncol. 2014 Jun;36(2):134-5.
20 Kemal Y, Yucel I, Ekiz K, Demirag G, Yilmaz B, Teker F, Ozdemir M. '' Elevated serum neutrophil to lymphocyte and platelet to lymphocyte ratios could be useful in lung cancer diagnosis ''. Asian Pac J Cancer Prev. 2014;15(6):2651-4.
21 Yılmaz B, Kemal Y, Teker F. Be careful before prescribing warfarin and octreotide together: a new drug-drug interaction report. Hippokratia. 2014 Oct-Dec;18(4):377
22 Nurettin Suna, Bülent Yalçın, Ahmet Şiar Ekinci, Onur Aydınlı, Ahmet Demirkazık, İsmail Savaş, Nurullah Zengin, Zeynep Bıyıklı, Fatih Teker, Haliz Yerlikaya, Fikri İçli. Evaluation of quality of life in patients with advanced stage non-small cell lung cancer who may or may not receive Second-Line chemotherapy. AOT 2015. 18189 53-62.
23 Hande Atalay, Fatih Teker, Banu Boyuk, Aslan Çelebi, Yavuz Ayar, İsmail Ekizoğlu. A case of Deep Vein Thrombosis in the postpartum period. JAREM 2015; 5:28-30.
24 Idris Yucel, Fatih Teker, Yasemin Kemal, Ahmet Siyar Ekinci, Bahiddin Yilmaz, Engin Kut Effect of body mass index on chemotherapy-induced neutropenia in breast cancer. 2016 Asco Annual Meeting (Poster)
25 Hande Atalay, Banu Boyuk, Muhammed Ateş, Aslan Çelebi, Ismail Ekizoğlu, Didik Arzu, Teker Fatih, Igdem Ayşenur. Idiopathic Intrahepatic Cholestasis; An Unusual Presentation Of Hodgkin's Disease. (2015) 24th Conference Of Asian-Pacific Association For The Study Of The Liver (Poster)
26 Bahiddin Yilmaz, Dilek Erdem, Fatih Teker, Ibrahim Goren, Beytullah Yildirim, Engin Kut, Derya Sarikaya, Idris Yucel. The Effect of Anticancer Therapy on Anti-HBS in Patients with Hematological Malignancies and Solid Tumors (2015) 4 th Mediterranean Multidisciplinary Oncology Forum
27 Erdem Dilek, Yilmaz Bahiddin, Fatih Çilingir, Kocasaraç Selim, Teker Fatih, Demirağ Güzin, Yücel Idris. Breast Cancer In Elderly. 2013 Asco Annual Meeting (Poster)
28 Erdem Dilek, Yücel Idris, Yilmaz Bahiddin, Demirağ Güzin, Kut Engin, Fatih Çilingir, Yasemin Kemal, Teker Fatih. Brain Metastases In Gastrointestinal Cancers. Esmo 2012 Congress (Poster)
29 Karadağ Berrin, Teker Fatih, Sema Ucak, Hikmet Bayer, Nazif Bağriaçik, Ali Ipbüker, Yüksel Altintaş. Relationship Of Pro-Bnp And Microalbuminuria In Diabetic Patients. 8th Congress Of The European Federation Of Internal Medicine (Poster)
30 Erdem Dilek, Yücel Idris, Yilmaz Bahiddin, Demirağ Güzin, Teker Fatih, Kemal Yasemin. Baseline Lymphopenia As A Prognostic Marker For Colorectal Carcinoma. 2012 Asco Annual Meeting (Poster)
31 Karadağ Berrin, Teker Fatih, Sema Yavaş, Hikmet Bayer, Nazif Bağriaçik, Ali Ipbüker, Yüksel Altuntaş Are Pro-Bnp Levels Different In Diabetic And Nondiabetic Patients? 8th Congress Of The European Federation Of Internal Medicine (Poster)
32 Teker Fatih (2019), A Rare Case of Gastric Metastastasis From Lung Cancer. 10. EHOC
33 Teker Fatih (2019), Approach to Central Nervous System Metastases. 5th Black Sea Breast Congress
34 Teker Fatih (2019), Cancer in Türkiye and Gaziantep. Workshop on Interdisciplinary Approaches in Cancer Research
35 Teker Fatih (2019), New Treatments in Patients with Bone Metastases. Course on Immuno-Oncological and Molecular Oncological Therapies in Cancer
36 Teker Fatih (2019), Good Clinical Practice Example in Oncology, 23rd National Cancer Congress
37 Teker Fatih (2019), New treatment strategies in locally recurrent/metastatic head and neck cancer? 2nd Congress on Oncology with Young People
38 Teker Fatih (2019), Chemotherapy and Immunotherapy in Cancer. Sanko University II. Nutrition and Dietetics Days Cancer and Nutrition Symposium
39 Teker Fatih (2019) Leser Trelat Symptom in the Diagnosis of Gastric Adenocarcinoma: Case Report. 3rd National Immunotherapy and Oncology Congress
40 Teker Fatih (2019), 2018 Concept in Castration-resistant disease Turkish Academy of Urology Multidisciplinary Urooncology Meeting
41 Teker Fatih (2019), Choose Your Health, Diagnose Your Cancer Early, Iskenderun Breast Cancer Panel
42 Teker Fatih (2018), Real Life Data and Cases on Abiraterone Acetate in Prostate Cancer. Turkish Urology Association Southeastern Branch October Scientific Meeting
43 Teker Fatih (2018), Use of PARP, VEGF and m-TOR inhibitors in ovarian cancer, Turkish Gynecology Oncology Association South - Southeastern Gynecological Oncology Regional Meeting
44 Teker Fatih (2018), Comparison of Clinical and Radiological Features According to EGFR Mutation Status in Metastatic Lung Adenocarcinoma Patients Using Erlotinib. Current Developments in Cancer Symposium - Lung Cancer Symposium
45 Teker Fatih (2018) Adult-Onset Langerhans Cell Histiocytosis Originating from the Thyroid Gland: Case Report'2. National Immunotherapy and Oncology Congress
46 Teker Fatih, Kut Engin, Yücel İdris (2015). Histopathological Subtypes of Breast Cancer Patients Over 65 Years of Age, Single Center Experience. 3rd Black Sea Breast Congress
47 Teker Fatih, Kut Engin, Yücel İdris (2015). Stage 1 Breast Cancer That Developed Metastasis After 13 Years. 3rd Black Sea Breast Congress
48 Yasemin Kemal, Demirağ Güzin, Ekiz Kubilay, Yilmaz Bahiddin, Teker Fatih, Kut Engin, Yücel İdris (2015) Is Mean Platelet Volume a Useful Marker in the Follow-up of Patients with Ovarian Cancer? 5th Turkish Medical Oncology Congress
49 Teker Fatih, Kut Engin, Yücel İdris (2015). Case Report of Small Cell Lung Cancer Presenting Like Bilateral Breast Cancer. 3rd Black Sea Breast Congress
50 Kut Engin, Teker Fatih, Yarar Zeliha, Gün Yener, Yilmaz Bahiddin, Yücel İdris (2015). A Case of Breast Cancer Developing After Kidney Transplantation. 3rd Black Sea Breast Congress
51 Kut Engin, Teker Fatih, Baş Berk, Evdirir Zeynep, Yilmaz Bahiddin, Yücel İdris (2015). A Case of Ovarian Cancer Presenting with a Mass in the Breast. 3rd Black Sea Breast Congress
52 Kut Engin, Teker Fatih, Işikli Gülşen, Okuma Muhammed, Özdemir Meltem, Yilmaz Bahiddin, Yücel İdris (2015). Secondary Neoplasm and Malignant Melanoma of the Breast. 3rd Black Sea Breast Congress
53 Teker Fatih, Kut Engin, Yücel İdris (2015). Our Breast Cancer Cases Under Thirty-five Years Old. 3rd Black Sea Breast Congress
54 Yasemin Kemal, Demirağ Güzin, Teker Fatih, Kut Engin, Yücel İdris (2015). The Relationship between Body Mass Index and Prognostic Factors in Breast Cancer. 3rd Black Sea Breast Congress
55 Yasemin Kemal, Yücel İdris, Teker Fatih, Demirağ Güzin, Yilmaz Bahiddin, Kut Engin (2014) Vemurafenib and Dress Syndrome. 5th Turkish Medical Oncology Congress
56 Yasemin Kemal, Yücel İdris, Demirağ Güzin, Yilmaz Bahiddin, Teker Fatih, Kut Engin, Ekiz Kubilay, Özdemir Meltem (2014). Is Increased Inflammatory Markers in Complete Blood Count Important in Lung Cancer? 5th Turkish Medical Oncology Congress
57 Teker Fatih, Yasemin Kemal, Demirağ Güzin, Yilmaz Bahiddin, Yücel İdris (2014). Lung Cancer Presenting with Pemphigus Vulgaris: Case Report. 5th Turkish Medical Oncology Congress
58 Yilmaz Bahiddin, Erdem Dilek, Kemal Yasemin, Teker Fatih, Demirağ Güzin, Yücel İdris (2013). A Case of Primary Gastric Melanoma. 20th National Cancer Congress
59 Yasemin Kemal, Demirağ Güzin, Yilmaz Bahiddin, Ekiz Kubilay, Teker Fatih, Yücel İdris (2013). A Case Who Developed Retinopathy Due to Interferon Treatment. 20th National Cancer Congress
60 Erdem Dilek, Okutur Sadi Kerem, Eren Orhan Önder, Şahin Nilgün, Teker Fatih, Yilmaz Bahiddin, Yücel İdris (2013). Skin Metastasis as a Very Rare Presentation in Metastatic Colorectal Cancer. 20th National Cancer Congress
61 Demirağ Güzin, Erdem Dilek, Yücel İdris, Yilmaz Bahiddin, Kut Engin, Fatih Çilingir, Yasemin Kemal, Teker Fatih (2012). Colorectal Cancer, a Rare Origin of Bone Metastasis. 4th Medical Oncology Congress
62 Teker Fatih, Erdem Dilek, Yilmaz Bahiddin, Yücel İdris, Demirağ Güzin, Yasemin Kemal (2012). A Case of Wilms Tumor in a 19-Year-Old Person. 4th Medical Oncology Congress
63 Hande Atalay, Fatih Teker, Banu İlk, Aslan Çelebi, Mehmet Erhan Sayalı, İsmail Ekizoğlu (2011) A Case of Deep Vein Thrombosis Due to Heterozygous Factor V Leiden Mutation and Activated Protein C Resistance in the 4th Week Postpartum. 13th National Internal Medicine Congress
64 Erdem Dilek, Yücel İdris, Yilmaz Bahiddin, Demirağ Güzin, Yasemin Kemal, Teker Fatih (2012). Secondary Malignancies in Colorectal Cancers. 4th Medical Oncology Congress
65 Erdem Dilek, Yücel İdris, Yilmaz Bahiddin, Demirağ Güzin, Kut Engin, Fatih Çilingir, Yasemin Kemal, Teker Fatih (2012). Cranial Metastasis in Gastrointestinal Cancers. 4th Medical Oncology Congress
66 Yasemin Kemal, Yilmaz Bahiddin, Erdem Dilek, Teker Fatih, Demirağ Güzin, Yücel İdris (2012). Krukenberg Tumor 11 Years After Subtotal Gastrectomy. 4th Medical Oncology Congress
67 Erdem Dilek, Yücel İdris, Yilmaz Bahiddin, Demirağ Güzin, Yasemin Kemal, Teker Fatih (2012). Single Center Experience on Ovarian Metastasis in Colorectal Cancer. 4th Medical Oncology Congress
68 Erdem Dilek, Yücel İdris, Yilmaz Bahiddin, Demirağ Güzin, Yasemin Kemal, Teker Fatih, Kut Engin, Çilingir Fatih (2012). Pancreas is a Rare Metastasis Site of Lung Cancer. 4th Medical Oncology Congress
69 Yücel İdris, Erdem Dilek, Yilmaz Bahiddin, Demirağ Güzin, Yasemin Kemal, Teker Fatih (2012). Skin Metastasis of Ovarian Cancer is a Rare Presentation. 4th Medical Oncology Congress
70 Erdem Dilek, Yücel İdris, Yilmaz Bahiddin, Demirağ Güzin, Yasemin Kemal, Teker Fatih (2012). Pretreatment Lymphopenia May Be an Important Prognostic Indicator in Colorectal Cancer. 4th Medical Oncology Congress
71 Teker Fatih,Çelebi Aslan,İlk Banu,Sayali Erhan,Ekizoğlu İsmail,Ayar Yavuz,Yücel Hatice, Erman Hande (2010). Recurrent Polychondritis: Case Report. 12th National Internal Medicine Congress
72 Karadağ Berrin, Teker Fatih, Hikmet Bayer, Ali İpbüker, Nazif Bağriaçik (2009). Comparison of Waist Circumference, Waist/Height Ratio, BMI and HbA1c in Type-2 Diabetic Patients 45th National Diabetes Congress
73 Fatih Teker, Berrin Karadağ, Hikmet Bayer, Ali İpbüker, Nazif Bağrıaçık (2009) Comparison of Education Level and Diet Compliance and Diabetic Complications. 45th National Diabetes Congress
74 Berrin Karadağ, Fatih Teker, Hikmet Bayer, Ali İpbüker, Nazif Bağrıaçık (2009) Documentation of 4-Hour OGTT and Insulin Results in 644 Healthy People. 45th National Diabetes Congress
75 Karadağ Berrin, Teker Fatih, Hikmet Bayer, Ali İpbüker, Bagriaçik Nazif (2008). Are PRO-BNP Levels Different in Diabetics and Non-Diabetics? 44th National Diabetes Congress
Covid-19 sequelae in 76 Oncology Hematology Patients, COVID SEQUELAES, Academician Publishing House 2021
77 Probiotics and Cancer, MICROBIA, Academician Publishing House 2020
78 Metastatic Castration-Resistant Prostate Cancer Treatment, Urological Oncology Bulletin 2019

• ASCO - 2013
• ESMO - 2012
• TÜRK TIBBİ ONKOLOJİ DERNEĞİ - 2011
• Türk Tabipler Birliği - 2024
• TÜRK İÇ HASTALIKLARI DERNEĞİ - 2009
• ARBİS - 2009

• Certificate of Appreciation given by Muammer Güler, Governor of Istanbul, 2010